Press release
Companion Diagnostics Market - Industry Analysis, Forecast, and Growth Opportunity
Stratview Research announces the launch of a new research report on the Companion Diagnostics Market. This extensive report from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025 under the following segments:• By Indication - Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases
• By Technology - PCR, IHC, NGS, ISH
• By Testing Facility - Hospital Laboratories, Independent Clinical Laboratories, Others
• By Region - North America, Western Europe, Asia-Pacific, Latin America, Rest of the World
Click here to request the detailed TOC of the report:
https://www.stratviewresearch.com/toc/409/companion-diagnostics-market.html
OR
Request a sample here:
https://www.stratviewresearch.com/Request-Sample/409/companion-diagnostics-market.html
Companion Diagnostics: Most important tools for the implementation of personalized medicine:
Companion diagnostics are considered as one of the most important tools for the implementation of personalized medicine. This enables the physician in identifying a specific biomarker that could indicate the patients most likely outcome-based combination of therapies or even specific treatment regimen.
InVentiv Health's survey (2017 by Jessica Lee, Ravi Patel, David Ruch and Katya Magonova) with practicing oncologists in the US predicted that 90% of the participating physician (n=30 out of total pool of 85) might accept a multi-biomarker diagnostic tool as the standard of care in the next three to five years. Can the results from 30 oncologists predict an accurate demand trend in the US market? But what about the other regions? What will be the adoption rate in the EU5, major markets such as China, Korea, Japan, Singapore and Australia?
Companion diagnostics that can help identify the right patient for the right drug at the right time:
Companion diagnostics that can help identify the right patient for the right drug at the right time are playing a major role in this trend. Companies like Astellas, Takeda, Astra Zeneca are making in-roads in this market. This report will help the reader look at the market from 360-degree view, while the in-depth demand analysis will help the manufacturer prioritize the right segment, the hurdles and issues faced by the manufacturers will also help the policy makers realize where to cap the price and where all to subsidize. The comprehensive study will encompass the demand and supply side of the market to help the reader get a complete top down approach of the companion diagnostic market.
Why Stratview Research
Our report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook
Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html
About Stratview Research
Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.
Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market - Industry Analysis, Forecast, and Growth Opportunity here
News-ID: 1455376 • Views: …
More Releases from Stratview Research
Metal Matrix Composite Market to Reach USD 472 Million by 2028, Says Stratview R …
The Metal Matrix Composite (MMC) Market, encompassing advanced materials made by reinforcing metal matrices with particles, fibers, or whiskers to combine metals' strength with superior stiffness and wear resistance, is set for robust growth in the coming years. According to Stratview Research, the market is projected to reach USD 472 million by 2028 from its base value in 2022, growing at a CAGR of 6 % during 2023-2028. The most…
Metal Bellows Market to Reach USD 1.4 Billion by 2032, Says Stratview Research
The Metal Bellows Market, which comprises flexible, corrugated metal components used to accommodate motion, absorb vibration, and maintain hermetic seals in high-pressure and extreme-environment applications, is expected to grow steadily over the next decade. According to Stratview Research, the global metal bellows market is projected to reach USD 1.4 billion by 2032, up from approximately USD 1.0 billion in 2024, exhibiting a CAGR of 3.8 % during the forecast period…
Meta-Aramid Fiber Market to Reach USD 1.67 Billion by 2034, Says Stratview Resea …
The Meta-Aramid Fiber Market - centered on high-performance synthetic fibers known for superior heat and flame resistance - is projected to grow significantly over the coming decade. According to Stratview Research, the global market is anticipated to reach USD 1.67 billion by 2034 from an estimated USD 1.22 billion in 2024, registering a CAGR of 2.9 % during 2025-2034. This growth is primarily driven by rising demand for flame-resistant, high-temperature…
Cold Plasma Market to Reach USD 3.1 Billion by 2027, Says Stratview Research
The Cold Plasma Market refers to the global industry focused on cold plasma technology-a partially ionized gas containing ions, electrons, and reactive species-used across industries for surface treatment, cleaning, activation, coating, decontamination, and other advanced processes. According to Stratview Research, the cold plasma market is projected to reach USD 3.1 billion by 2027, growing at a CAGR of 12.5% during the forecast period of 2022-2027. The single most important growth…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
